ASCO Draft Recommendations For Cancer Trial Endpoints
This article was originally published in The Pink Sheet Daily
Executive Summary
The American Society of Clinical Oncology’s Cancer Research Committee has published recommendations for endpoints in Phase III trials for four different kinds of cancer and is accepting comment from stakeholders until May 1.